HCSGD entry for CSNK2A2
1. General information
Official gene symbol | CSNK2A2 |
---|---|
Entrez ID | 1459 |
Gene full name | casein kinase 2, alpha prime polypeptide |
Other gene symbols | CK2A2 CSNK2A1 |
Links to Entrez Gene | Links to Entrez Gene |
2. Neighbors in the network

This gene isn't in Literature mining network.
3. Gene ontology annotation
GO ID | GO term | Evidence | Category |
---|---|---|---|
GO:0000278 | Mitotic cell cycle | TAS | biological_process |
GO:0004672 | Protein kinase activity | IEA | molecular_function |
GO:0004674 | Protein serine/threonine kinase activity | IEA | molecular_function |
GO:0005515 | Protein binding | IPI | molecular_function |
GO:0005524 | ATP binding | IEA | molecular_function |
GO:0005634 | Nucleus | IDA | cellular_component |
GO:0005829 | Cytosol | TAS | cellular_component |
GO:0006351 | Transcription, DNA-templated | IEA | biological_process |
GO:0006355 | Regulation of transcription, DNA-templated | IEA | biological_process |
GO:0006915 | Apoptotic process | IEA | biological_process |
GO:0007411 | Axon guidance | TAS | biological_process |
GO:0016055 | Wnt signaling pathway | IEA | biological_process |
GO:0031519 | PcG protein complex | IDA | cellular_component |
GO:0047485 | Protein N-terminus binding | IPI | molecular_function |
GO:0051726 | Regulation of cell cycle | IEA | biological_process |
GO:0071174 | Mitotic spindle checkpoint | IMP | biological_process |
Entries Per Page
Displaying Page of
4. Expression levels in datasets
- Meta-analysis result
p-value up | p-value down | FDR up | FDR down |
---|---|---|---|
0.2595386080 | 0.6843202424 | 0.9531317409 | 1.0000000000 |
- Individual experiment result
( "-" represent NA in the specific microarray platform )
( "-" represent NA in the specific microarray platform )
Data source | Up or down | Log fold change |
---|---|---|
GSE11954 | Up | 0.4240025731 |
GSE13712_SHEAR | Down | -0.3562701581 |
GSE13712_STATIC | Down | -0.1569949272 |
GSE19018 | Down | -0.0367424459 |
GSE19899_A1 | Down | -0.0579954306 |
GSE19899_A2 | Up | 0.3203114715 |
PubMed_21979375_A1 | Up | 0.2915366663 |
PubMed_21979375_A2 | Up | 0.7887816880 |
GSE35957 | Down | -0.1444626627 |
GSE36640 | Down | -0.3911474061 |
GSE54402 | Up | 0.0816043964 |
GSE9593 | Up | 0.3829338401 |
GSE43922 | Up | 0.0008759574 |
GSE24585 | Down | -0.1812929355 |
GSE37065 | Down | -0.0916877927 |
GSE28863_A1 | Up | 0.4060736067 |
GSE28863_A2 | Up | 0.3662078806 |
GSE28863_A3 | Down | -0.2019693228 |
GSE28863_A4 | Down | -0.0649200211 |
GSE48662 | Up | 0.1328913204 |
5. Regulation relationships with compounds/drugs/microRNAs
- Compounds
Not regulated by compounds
- Drugs
Name | Drug | Accession number |
---|---|---|
[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid | DB07546 | - |
- MicroRNAs
- mirTarBase
MiRNA_name | mirBase ID | miRTarBase ID | Experiment | Support type | References (Pubmed ID) |
---|---|---|---|---|---|
hsa-miR-1 | MIMAT0000416 | MIRT024100 | Proteomics | Functional MTI (Weak) | 18668040 |
Entries Per Page
Displaying Page of